GoodRx (GDRX) said Monday it is expanding the availability of Amgen's (AMGN) cholesterol drug Repatha at a lower price.
Starting Monday, patients will be able to use GoodRx to buy Repatha for $239 at over 70,000 pharmacies in the US, GoodRx said, adding that the price represents a savings of about 60% off the retail pharmacy list price.
GoodRx shares were up 3.5% in early trading, while Amgen was down 0.5%.
Price: 4.69, Change: +0.16, Percent Change: +3.53
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.